The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study
Journal of Oral Pathology & Medicine · 2025
DOI: 10.1111/jop.13591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, 2025. Verfasst von Mengna Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Mucosal Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Lichen Planus, Oral, Chromones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Medical Innovation Center, Jiangsu Provincial Key Research and Development Program.
Abstract (Originalsprache)
Background
Oral lichen planus (OLP) is a T cell‐mediated immune disease. Iguratimod (IGU) is a novel immunomodulatory agent for rheumatoid arthritis. No studies have been reported on the mechanism of IGU in the treatment of OLP, which deserves investigation.
Methods
Samples were collected from two batches of non‐erosive OLP, erosive OLP (EOLP) patients and healthy control subjects. In the first batch, the effects of IGU or the same volume of dimethyl sulfoxide (DMSO) on proliferation, apoptosis and migration of peripheral blood T lymphocytes (PBL T) were examined by CCK‐8, flow cytometry and transwell assay respectively. The levels of IL‐6, IL‐17, TNF‐α, TGF‐β and IL‐10 were measured by enzyme‐linked immunosorbent assay. In the second batch, the percentages of Th17 and Treg cells were determined by flow cytometry in peripheral blood mononuclear cells after IGU or DMSO stimulation.
Results
Compared with the control, IGU promoted apoptosis and inhibited migration, but had no significant effect on the proliferation of PBL T in OLP. IL‐6, IL‐17 and TNF‐α were decreased in OLP. TGF‐β and IL‐10 showed an upward trend in the IGU‐treated EOLP. IGU decreased Th17 in OLP and reduced Th17/Treg ratio in EOLP. The percentage of Treg cells showed an upregulated trend but the difference was not statistically significant.
Conclusion
IGU may intervene in the immune response of OLP by affecting functions of PBL T, improving the balance of Th17/Treg and regulating related cytokines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Mucosal Diseases, The Affiliated Stomatological Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- State Key Laboratory Cultivation Base of Research, Prevention and Treatment for Oral Diseases, Nanjing, Jiangsu, China.
- Jiangsu Province Engineering Research Center of Stomatological Translational Medicine, Nanjing, Jiangsu, China.
- The Affiliated Stomatological Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Jiangxi Provincial Key Laboratory of Oral Diseases, Nanchang, Jiangxi, China.
- Jiangxi Provincial Clinical Research Center for Oral Diseases, Nanchang, Jiangxi, China.
ORCID-Profile: Yuan Fan, Liqun Yang, Yuchi Zhu
Förderung
- National Natural Science Foundation of China
- Jiangsu Provincial Medical Innovation Center
- Jiangsu Provincial Key Research and Development Program
- Jiangsu Province Capability Improvement Project through Science, Technology and Education-Jiangsu Provincial Research Hospital Cultivation Unit
Zitieren
APA
Zhang, M., Cheng, J., Liu, J., Geng, Y., Fan, Y., Yang, L., & Zhu, Y. (2025). The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13591
Vancouver
Zhang M, Cheng J, Liu J, Geng Y, Fan Y, Yang L, et al. The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study. Journal of Oral Pathology & Medicine. 2025. doi:10.1111/jop.13591
BibTeX
@article{Zhang2025,
author = {Zhang, Mengna and Cheng, Juehua and Liu, Jia and Geng, Yanlin and Fan, Yuan and Yang, Liqun and Zhu, Yuchi},
title = {The Mechanism of Immune Intervention by Iguratimod in Oral Lichen Planus Patients: An In Vitro Experimental Study},
journal = {Journal of Oral Pathology & Medicine},
year = {2025},
doi = {10.1111/jop.13591}
}
EUVIMED